Vitamin D3 vs. D2: Why the Form Matters More Than You Think

Vitamin D3 or D2?

October 26, 2025

Contributing Authors: Team TRILITY / ACEND

For years, vitamin D supplementation has been treated as one of those “check-the-box” essentials — take a capsule and move on. But new research from Nutrition Reviews reveals that not all vitamin D is created equal. Specifically, vitamin D₂ (ergocalciferol) may actually lower levels of the more potent form, vitamin D₃ (cholecalciferol), in the body.

This surprising discovery challenges decades of assumptions and reinforces why medical food formulations — such as ACEND® for Chronic Inflammation — use vitamin D₃ exclusively to support optimal metabolic, immune, and neuromuscular health.

Vitamin D Deficiency: A Global Health Issue

Nearly 1 in 4 Americans have moderate to severe vitamin D deficiency. That’s more than 80 million people with low serum levels of 25-hydroxyvitamin D — the biomarker used to assess vitamin D status.

This deficiency isn’t a trivial matter. Low vitamin D is strongly associated with:

Rickets and osteomalacia (bone demineralization)
Increased fracture risk and osteoporosis
Cardiovascular and metabolic conditions
Autoimmune diseases and immune dysfunction
Cognitive decline and depression【1–5】

Vitamin D’s role extends far beyond bone health. It regulates over 200 genes involved in inflammation, insulin response, calcium transport, and immune defense【6】. In fact, some experts now consider vitamin D status a biological indicator of chronic inflammation — one of the hallmarks of aging.

The Critical Difference Between D₂ and D₃

Chemically, vitamin D₂ and D₃ differ only slightly — one is plant-derived (D₂ from yeast and fungi), the other is synthesized in human skin upon sunlight exposure or obtained from animal sources like fish, eggs, and dairy. Yet this small structural difference translates into major physiological divergence.

1. Bioavailability and Stability

Vitamin D₃ is more efficiently absorbed and converted to 25(OH)D₃, the primary circulating form of vitamin D. Studies show that D₃ raises blood levels up to 87% higher and maintains them for longer durations compared to D₂【7–9】.

2. Interaction and Suppression

The new Nutrition Reviews meta-analysis (University of Surrey, 2025) analyzed 11 randomized controlled trials and found that D₂ supplementation actually reduced circulating D₃ levels — even more than in placebo groups. That means D₂ can counteract some of D₃’s biological benefits.

“Vitamin D₂ supplements can actually decrease levels of vitamin D₃ in the body,” said study author Dr. Emily Brown. “These results suggest D₃ supplementation may be more beneficial for most individuals.”

3. Immune and Neuroendocrine Effects

Only D₃ — not D₂ — was shown to stimulate interferon expression, a key component of immune defense against viral and bacterial infections【10】. D₃ is also more strongly linked with reduced cancer-related mortality, better mood regulation, and lower inflammatory cytokine levels【11–13】.

Vitamin D and Chronic Inflammation

Low vitamin D correlates with higher systemic inflammation, as indicated by elevated CRP (C-reactive protein) and IL-6 levels. Conversely, D₃ supplementation can:

Downregulate pro-inflammatory cytokines (IL-1β, TNF-α)
Increase anti-inflammatory IL-10
Improve mitochondrial oxidative phosphorylation in muscle and immune cells
Support T-regulatory cell balance (key for autoimmune modulation)【14–18】

This immune-regulatory effect is one reason ACEND® incorporates D₃ in its medical food design — not just as a vitamin, but as a precision nutrient supporting the resolution phase of inflammation.

Why ACEND® Chooses Vitamin D₃

ACEND’s formulation uses vitamin D₃ (cholecalciferol) — never D₂ — and combines it with magnesium citrate, boron glycinate, and vitamin K₂ (as menaquinone-7) to create a synergistic nutrient triad for calcium metabolism and endothelial function.

Here’s why that matters:

Magnesium activates the enzymes that convert D₃ into its active form, calcitriol.
Boron helps extend D₃’s half-life and enhances bone and hormone metabolism.
Vitamin K₂ directs calcium away from arteries and into bone, reducing vascular calcification risk.

This co-nutrient synergy ensures that ACEND’s D₃ doesn’t just raise serum levels — it translates into functional benefits at the cellular level: better immune surveillance, improved bone density, and lower oxidative stress.

Vitamin D, Mood, and Mitochondria

Emerging data show that vitamin D₃ supports brain health by influencing mitochondrial bioenergetics and neurotransmitter synthesis. Deficiency has been associated with impaired dopamine signaling, greater fatigue, and higher rates of seasonal affective disorder (SAD).

Because D₃ can cross the blood–brain barrier, it acts directly on glial and neuronal cells to reduce neuroinflammation and improve cognitive performance【19–21】.

In this context, D₃ functions as both a neuroprotective and anti-inflammatory agent — aligning perfectly with ACEND’s mission to address the inflammatory root of multiple chronic conditions.

Key Takeaway

The new meta-analysis confirms what many clinicians have observed: vitamin D₃ is superior to D₂ in raising and maintaining healthy vitamin D levels — and D₂ may even blunt some of D₃’s benefits.

For individuals managing chronic inflammation, autoimmune symptoms, or mood dysregulation, D₃ should be the form of choice.

ACEND® integrates vitamin D₃ in a balanced, evidence-based matrix to optimize absorption, safety, and therapeutic value — a distinction that matters when targeting inflammation at its core.

References

Holick MF. N Engl J Med. 2007;357:266–281.
Bouillon R et al. Nat Rev Endocrinol. 2019;15(8):479–496.
Amrein K et al. Crit Care. 2020;24:223.
Sizar O et al. StatPearls. 2025.
Binkley N et al. J Clin Endocrinol Metab. 2011;96:E447–E452.
Carlberg C, Haq A. Nutrients. 2022;14(3):521.
Tripkovic L et al. Am J Clin Nutr. 2012;95(6):1357–1364.
Biancuzzo RM et al. J Clin Endocrinol Metab. 2013;98(11):4339–4345.
Ovesen L et al. Eur J Nutr. 2021;60:2635–2645.
Martineau AR et al. Front Immunol. 2020;11:2388.
Keum N et al. J Clin Oncol. 2023;41(4):894–903.
Rejnmark L et al. BMJ. 2024;384:e075487.
Wang TJ et al. Arch Gen Psychiatry. 2019;66(3):300–307.
Prietl B et al. Nutrients. 2013;5(7):2502–2521.
Ketha H et al. J Steroid Biochem Mol Biol. 2023;230:106000.
Charoenngam N, Holick MF. Nutrients. 2020;12(2):E488.
Gombart AF et al. Nutrients. 2020;12(12):4091.
Bassatne A et al. Front Immunol. 2022;13:1005186.
Cui X et al. Mol Psychiatry. 2020;25:1432–1450.
Török N et al. Int J Mol Sci. 2023;24(2):1350.
Mokry LE et al. Neurobiol Aging. 2022;113:101–113.